Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2000
04/05/2000CN1249679A Transdermal therapeutic system
04/05/2000CN1249677A Composition for external use
04/05/2000CN1249176A Soft chew tablet
04/05/2000CN1051081C Method for preparing inclusion complexes of 3-morpholino-sydnonimine
04/05/2000CN1051080C Method for preparing pharmaceutical composition contg. substd. sydnonimine or salts
04/05/2000CN1050993C Drug with effect of resisting and preventing tension and intelligence promoting
04/04/2000US6046289 For inhibiting coagulation of blood platelets, inhibiting adhesion of animal cells, or as substrate for culturing animal cells
04/04/2000US6046277 Coating composition contains polyvinyl acetate, a n-vinylpyrrolidone containing polymer, a water soluble or swellable substance, a water insoluble dusting agent and optionally additives; controlled release
04/04/2000US6046244 Composition comprising prostaglandin e1, skin penetration enhancer, polysaccharide gum, lipophilic compound, acidic buffer system
04/04/2000US6046240 Methods for treating female sexual dysfunction
04/04/2000US6046230 Stable injection formulation containing paclitaxel
04/04/2000US6046177 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
04/04/2000US6046163 Cyclosporin formulation
04/04/2000US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression
04/04/2000US6045829 Having increased rate and uniformity of absorption in vivo
04/04/2000US6045828 Mixture of crystalline, hydrophilic carrier and freeze dried, single phase particles comprising a biologically active component and a lipid component having a phase transition temperature below 37 degrees c
04/04/2000US6045827 Treatment of equine laminitis
04/04/2000US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis
04/04/2000US6045820 Iodinated strong base anion exchange resin antiseptic particles attached to a carrier material whereby the antiseptic leaves no halogen residue in sterilized fluid or bodily wound sites
04/04/2000US6045815 An antifungal composition including a dipolar aprotic solvent and an aqueous secondary solvent
04/04/2000US6045809 A drug mixture consisting of prolamines and polymer films derived from prolamines with good bioavailability and therapeutic efficacy; treating inflammation
04/04/2000US6045808 Method for removing high boiling solvents from drug formulations by vacuum drying
04/04/2000US6045778 Stabilized medicinal aerosol solution formulations
04/04/2000CA2173878C Polynucleotide for treating systemic lupus erythematosus
04/04/2000CA2140053C Collagen-based injectable drug delivery system and its use
04/04/2000CA2136607C Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
04/04/2000CA2031129C Chimeric antibody for detection and therapy of infectious and inflammatory lesions
04/04/2000CA2006975C Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
03/2000
03/30/2000WO2000017294A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin
03/30/2000WO2000016818A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000WO2000016814A1 Medicinal aerosol formulation
03/30/2000WO2000016808A2 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
03/30/2000WO2000016807A1 Cationic compounds and their use as macro molecular carriers
03/30/2000WO2000016775A1 Topical formulation of alkyl-, phenyl-pyridone
03/30/2000WO2000016774A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
03/30/2000WO2000016752A2 Transdermal devices comprising essential oils for aromatherapy
03/30/2000WO2000016751A1 Fentanyl composition for the treatment of acute pain
03/30/2000WO2000016750A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000WO2000016749A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000WO2000016748A1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
03/30/2000WO2000016747A1 Agitation-independent pharmaceutical multiple unit retard preparations and method for the production thereof
03/30/2000WO2000016745A2 Micronised pharmaceutical compositions
03/30/2000WO2000009096B1 Injectable formulations of nanoparticulate naproxen
03/30/2000WO2000003680A3 Emollient esters based upon capryl alcohol and isostearic acid
03/30/2000WO2000002601A3 Transdermal delivery system
03/30/2000WO2000002584A3 Cancer treatment methods using antibodies to aminophospholipids
03/30/2000WO2000002576A3 Egf-genistein for prevention of restenosis
03/30/2000WO2000000120A9 Methods and transdermal compositions for pain relief
03/30/2000WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
03/30/2000WO1999062536A3 Pharmaceutical formulations for igf/igfbp
03/30/2000WO1999061066A9 Convection-enhanced delivery of aav vectors
03/30/2000WO1999049892A3 Use of active p40 conjugates for nasal delivery
03/30/2000CA2820588A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2629988A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2344440A1 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
03/30/2000CA2344396A1 Transdermal devices comprising essential oils for aromatherapy
03/30/2000CA2344215A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000CA2342742A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000CA2342732A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin
03/30/2000CA2310433A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparation containing pyridonecarboxylic acid and production method thereof
03/29/2000EP0989137A2 Diagnostic agents for pancreatic exocrine function
03/29/2000EP0988863A2 Stable complexes of poorly soluble compounds
03/29/2000EP0988861A1 Stabilized protein compositions
03/29/2000EP0988797A1 Compositions for postgastrectomic mineral supply
03/29/2000EP0988550A1 Formulation for immunological reaction systems
03/29/2000EP0988374A1 Hydrophilic composition containing protease produced by vibrio
03/29/2000EP0988324A1 Method for manufacturing pure guar meal
03/29/2000EP0988322A1 Ultra-fine microcrystalline cellulose compositions and process for their manufacture
03/29/2000EP0988108A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
03/29/2000EP0988061A1 Methods for delivering bioactive agents
03/29/2000EP0988059A2 Human quinone reductase 2 conjugates for adept and gdept
03/29/2000EP0988058A2 Covalent conjugates of topoisomerase i and topoisomerase ii inhibitors
03/29/2000EP0988057A1 Drug targeting
03/29/2000EP0988056A2 Tissue factor methods and compositions for coagulation and tumor treatment
03/29/2000EP0988055A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
03/29/2000EP0988049A2 Pharmaceutical composition for treating hepatitis b virus (hbv) infection
03/29/2000EP0988046A1 Oil-free pharmaceutical compositions containing cyclosporin a
03/29/2000EP0988033A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol
03/29/2000EP0988030A1 Knobby nanospheres
03/29/2000EP0988029A1 Device and methods for wound treatment
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0778731B1 Ionene polymers containing biologically-active anions
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000EP0697891B1 Polyoxime compounds and their preparation
03/29/2000EP0620733B1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
03/29/2000CN1248914A Pharmaceutical composition
03/29/2000CN1248913A Pharmaceutical composition for programmed release of dexfenfluramine
03/29/2000CN1248911A Opthalmic non-irritating iodine medicament and method
03/29/2000CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process
03/29/2000CN1050763C Process for preparing topical medicinal composition capable of enhancing skin penetration
03/29/2000CN1050749C Anti-inflammatory analogesic plaster
03/29/2000CN1050748C Preparation process of surface anesthesia film
03/29/2000CA2281418A1 Use of a silicone gum to stabilize ascorbic acid and novel compositions containing these components
03/28/2000US6043390 Useful for the intracellular delivery of polynucleotides; cationic lipids useful in the preparation of liposomes and other lipid vesicles for the delivery of nucleic acids into mammalian cells
03/28/2000US6043339 Heterologous complex of polypeptides or nucleic acids which are linked to an importation competent signal peptide and to a nuclear localization peptide; for peptide and gene therapy and antisense agents
03/28/2000US6043276 Compounds obtained from salvia species having antiviral activity
03/28/2000US6043237 Use of photodynamic therapy for prevention of secondary cataracts
03/28/2000US6043215 Preparation of factor IX
03/28/2000US6043099 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
1 ... 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 ... 1712